Abstract

This proposal is for continued support for the Pediatric Oncology Group Statistical Office. The role of the Statistical Office in POG is to and data management expertise in the design, conduct and trials. It prepares the meeting agendas which summarize protocol activity and provides management reports to the committees on patient accrual and quality assurance. It is responsible for the Community Clinical Oncology Program for POG. The Statistical Office engages i n methodologic research and develops new applications of computer technology or new analytic approaches to facilitate group clinical trials. The Statistical Office is the central repository for POG patient records and, in collaboration with POG investigators, conducts cross-study and cross-disease analyses utilizing the valuable resource of 10 years of accumulated data to assess progress and provide direction for future protocol development.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA029139-12
Application #
3557042
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1980-12-01
Project End
1995-12-31
Budget Start
1992-01-01
Budget End
1992-12-31
Support Year
12
Fiscal Year
1992
Total Cost
Indirect Cost

  Institution

Name
University of Florida
Department
Type
Schools of Arts and Sciences
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611

  Publications

DuBois, Steven G; Mody, Rajen; Naranjo, Arlene et al. (2017) MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group. Pediatr Blood Cancer 64:
von Allmen, Daniel; Davidoff, Andrew M; London, Wendy B et al. (2017) Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma. J Clin Oncol 35:208-216
Sankaran, Hari; Danysh, Heather E; Scheurer, Michael E et al. (2016) The Role of Childhood Infections and Immunizations on Childhood Rhabdomyosarcoma: A Report From the Children's Oncology Group. Pediatr Blood Cancer 63:1557-62
Lupo, Philip J; Danysh, Heather E; Plon, Sharon E et al. (2015) Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database. Cancer Med 4:781-90
Lupo, Philip J; Zhou, Renke; Skapek, Stephen X et al. (2014) Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: a report from the Children's Oncology Group. Int J Cancer 134:431-6
Schultz, K R; Carroll, A; Heerema, N A et al. (2014) Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031. Leukemia 28:1467-71
Lupo, Philip J; Danysh, Heather E; Skapek, Stephen X et al. (2014) Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children's Oncology Group. Cancer Causes Control 25:905-13
Grufferman, Seymour; Lupo, Philip J; Vogel, Rachel Isaksson et al. (2014) Parental military service, agent orange exposure, and the risk of rhabdomyosarcoma in offspring. J Pediatr 165:1216-21
Tower, Richard L; Jones, Tamekia L; Camitta, Bruce M et al. (2014) Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group. J Pediatr Hematol Oncol 36:353-61
Mansour, Marc R; Abraham, Brian J; Anders, Lars et al. (2014) Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 346:1373-7

Showing the most recent 10 out of 268 publications